Related Experiment Video
Updated: Jul 2, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
Modulation of NOX2 causes obesity-mediated atrial fibrillation
Arvind Sridhar1,2, Jaime DeSantiago1, Hanna Chen1
1Division of Cardiology.
Abstract:
Obesity is linked to an increased risk of atrial fibrillation (AF) via increased oxidative stress. While NADPH oxidase 2 (NOX2), a major source of oxidative stress and reactive oxygen species (ROS) in the heart, predisposes to AF, the underlying mechanisms remain unclear. Here, we studied NOX2-mediated ROS production in obesity-mediated AF using Nox2-knockout mice and mature human induced pluripotent stem cell-derived atrial cardiomyocytes (hiPSC-aCMs). Diet-induced obesity (DIO) mice and hiPSC-aCMs treated with palmitic acid (PA) were infused with a NOX blocker (apocynin) and a NOX2-specific inhibitor, respectively. We showed that NOX2 inhibition normalized atrial action potential duration and abrogated obesity-mediated ion channel remodeling with reduced AF burden. Unbiased transcriptomics analysis revealed that NOX2 mediates atrial remodeling in obesity-mediated AF in DIO mice, PA-treated hiPSC-aCMs, and human atrial tissue from obese individuals by upregulation of paired-like homeodomain transcription factor 2 (PITX2). Furthermore, hiPSC-aCMs treated with hydrogen peroxide, a NOX2 surrogate, displayed increased PITX2 expression, establishing a mechanistic link between increased NOX2-mediated ROS production and modulation of PITX2. Our findings offer insights into possible mechanisms through which obesity triggers AF and support NOX2 inhibition as a potential novel prophylactic or adjunctive therapy for patients with obesity-mediated AF.
Insights
Obesity increases atrial fibrillation (AF) risk through oxidative stress. Inhibiting NADPH oxidase 2 (NOX2) reduced AF in obese mice and cells by normalizing ion channels and PITX2 expression.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Obesity is a significant risk factor for atrial fibrillation (AF), often mediated by increased oxidative stress.
- NADPH oxidase 2 (NOX2) is a key source of reactive oxygen species (ROS) in the heart, implicated in AF pathogenesis, but its precise role in obesity-related AF is not fully understood.
Purpose of the Study:
- To investigate the role of NOX2-mediated ROS production in obesity-induced AF.
- To elucidate the molecular mechanisms linking NOX2, oxidative stress, and AF in obesity.
Main Methods:
- Utilized diet-induced obesity (DIO) mouse models and human induced pluripotent stem cell-derived atrial cardiomyocytes (hiPSC-aCMs).
- Administered NOX blocker (apocynin) to DIO mice and a NOX2-specific inhibitor to PA-treated hiPSC-aCMs.
- Performed transcriptomics analysis and used hydrogen peroxide as a NOX2 surrogate.
Main Results:
- NOX2 inhibition normalized atrial action potential duration and reversed obesity-associated ion channel remodeling, reducing AF burden.
- Transcriptomics revealed NOX2 upregulates paired-like homeodomain transcription factor 2 (PITX2) in obesity-mediated AF.
- Increased NOX2-derived ROS directly correlated with elevated PITX2 expression in hiPSC-aCMs.
Conclusions:
- NOX2-mediated ROS production and subsequent PITX2 upregulation are key mechanisms in obesity-related atrial remodeling and AF.
- NOX2 inhibition presents a potential therapeutic strategy for managing obesity-associated AF.
More Related Videos
Related Concept Videos
Regulation of Metabolism
Nitric Oxide Signaling Pathway
Regulation of Heart Rates
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Obesity
Coronary Artery Disease II: Pathophysiology
Heart Failure II: Pathophysiology

